Evidence map›Paper›PMID 18366134›Full record

ReviewBiotechnology and bioengineering2008

Medical biofilms.

James D Bryers

Abstract readReview
In one paragraph

Review in Biotechnology and bioengineering, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 251 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecular imaging of bacterial biofilms-a systematic review.Critical reviews in microbiology · 2024
    Pooled it
  2. Article
  3. Article
  4. Mesolens imaging in microbiology.Essays in biochemistry · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Nanoengineered γ MnOLife (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Adhesion of antibiotic-resistant bacteria to patient-applied thermoplastic medical devices.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. VScientific reports · 2025
    Article

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

James D BryersDepartment of Bioengineering, University of Washington, Seattle, Washington 98195-5061, USA. jbryers@u.washington.edu

Funding

Periodontal Biomaterials with BITE (Biofilm Immunity with Tissue Engineering)R01DE018701 · NIDCR · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2008 to 2019
$5.0M
Biomaterials that Promote Infection ImmunityR01AI074661 · NIAID · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2008 to 2012
$2.5M
Biomaterials that Prevent Biofilm Colonization and Device-based InfectionsR01EB007575 · NIBIB · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2009 to 2012
$1.7M
NIAID NIH HHS R01 AI074661NIBIB NIH HHS R01 EB007575NIDCR NIH HHS R01 DE018701
6 · The paper itself

Abstract

For more than two decades, Biotechnology and Bioengineering has documented research focused on natural and engineered microbial biofilms within aquatic and subterranean ecosystems, wastewater and waste-gas treatment systems, marine vessels and structures, and industrial bioprocesses. Compared to suspended culture systems, intentionally engineered biofilms are heterogeneous reaction systems that can increase reactor productivity, system stability, and provide inherent cell:product separation. Unwanted biofilms can create enormous increases in fluid frictional resistances, unacceptable reductions in heat transfer efficiency, product contamination, enhanced material deterioration, and accelerated corrosion. Missing from B&B has been an equivalent research dialogue regarding the basic molecular microbiology, immunology, and biotechnological aspects of medical biofilms. Presented here are the current problems related to medical biofilms; current concepts of biofilm formation, persistence, and interactions with the host immune system; and emerging technologies for controlling medical biofilms.

Indexed as

BioreactorsBacterial AdhesionBacterial InfectionsBiofilmsDisinfectionEquipment ContaminationHumansSterilization

Identifiers

PMID18366134
PMCPMC2706312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.